MTNB Matinas Biopharma Holdings Inc

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company engaged in identifying & developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections.

As of 04/09/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/21/2014
Outstanding shares:  204,276,412
Average volume:  1,561,719
Market cap:   $206,319,176
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    576810105
ISIN:        US5768101058
Sedol:      BN65XQ6
Valuation   (See tab for details)
PE ratio:   -17.17
PB ratio:   3.38
PS ratio:   0.00
Return on equity:   -25.25%
Net income %:   -10,183.45%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy